Literature DB >> 20939739

p53 Codon 72 polymorphism and gastric cancer risk in a Chinese Han population.

Yong Zhou1, Ni Li, Wen Zhuang, Xiaoting Wu.   

Abstract

BACKGROUND: studies investigating the association between p53 codon 72 polymorphism and gastric cancer risk report conflicting results. Our recent meta-analysis suggests that the p53 codon 72 polymorphism may be associated with gastric cancer among Asians. AIM: the objective of this study was to investigate the association between p53 codon 72 polymorphism and gastric cancer risk in Chinese Han patients.
METHODS: we extracted the peripheral blood samples from 150 patients with gastric cancer and 150 control subjects. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed to detect p53 codon 72 polymorphism in these patients.
RESULTS: patients with gastric cancer had a significantly lower frequency of Arg/Arg (odds ratio [OR] = 0.48, 95% confidence interval [95% CI] = 0.28, 0.80; p = 0.005) than control subjects. Patients with cardia gastric cancer had a significantly higher frequency of Pro/Pro (OR = 2.26, 95% CI = 1.12, 4.55; p = 0.02) than those with noncardia gastric cancer. Patients with advanced gastric cancer had a significantly higher frequency of Arg/Arg (OR = 2.66, 95% CI = 1.06, 6.65; p = 0.03) than those with early gastric cancer. When stratified by the Lauren's classification, histological differentiation of gastric cancer, no statistically significant result was observed.
CONCLUSION: this study suggests that the p53 codon 72 polymorphism may be associated with gastric cancer in Chinese Han patients, and that difference in genotype distribution may be associated with the location and stage of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20939739     DOI: 10.1089/gtmb.2010.0115

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  6 in total

1.  Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population.

Authors:  Dazhong Liu; Fei Wang; Xiaotong Guo; Qiushi Wang; Wei Wang; Hao Xu; Guangquan Xu
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

2.  An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.

Authors:  Kui-Jie Liu; Hai-Zhi Qi; Hong-Liang Yao; San-Lin Lei; Zhen-Dong Lei; Tie-Gang Li; Hua Zhao
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

3.  Risk factors for gastric cancer in Latin America: a meta-analysis.

Authors:  Patricia Bonequi; Fernando Meneses-González; Pelayo Correa; Charles S Rabkin; M Constanza Camargo
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

4.  Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high-risk region.

Authors:  Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Ghasem Janbabaei; Versa Omrani-Nava; Yahya Hasheminasab; Omolbanin Amjadi; Mohsen Tehrani
Journal:  Biomed Rep       Date:  2018-02-22

Review 5.  Alterations of the TP53 gene in gastric and esophageal carcinogenesis.

Authors:  Marilanda Ferreira Bellini; Aline Cristina Targa Cadamuro; Maysa Succi; Marcela Alcântara Proença; Ana Elizabete Silva
Journal:  J Biomed Biotechnol       Date:  2012-08-07

6.  Long-term comparisons of the efficacy, safety, and pregnancy outcomes of adjuvant tamoxifen plus ovarian function suppression in premenopausal Han and Zhuang Chinese patients with hormone receptor-positive early breast cancer.

Authors:  Shicong Tang; Qiong Zhang; Xianghui Tang; Dong Chen; Fan Zhang; Jianlun Liu; Wei Wei; Dequan Liu
Journal:  J Int Med Res       Date:  2018-10-25       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.